Evidence map›Paper›PMID 21895032›Full record

Trial reportTechnology in cancer research & treatment2011

Electrochemotherapy: a new technological approach in treatment of metastases in the liver.

I Edhemovic, E M Gadzijev, E Brecelj, D Miklavcic, B Kos, A Zupanic, B Mali, T Jarm, D Pavliha, M Marcan and 7 more

Registry-linked trialOpen access · bronzeAbstract readCase ReportsClinical Trial, Phase IClinical Trial, Phase II
In one paragraph

Trial report in Technology in cancer research & treatment, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02352259 (Treatment of Liver Metastases With Electrochemotherapy), which is not on this map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
18.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02352259 phase2completednot on this mapstarted 2013, after this paper: background citation

Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II

TypeinterventionalSponsorInstitute of Oncology LjubljanaRan2013 to 2018Enrolled23ConditionsLiver MetastasesArmsElectrochemotherapy, Cliniporator Vitae®, Bleomycin PHC 15 e. (United States Pharmacopeia - USP)
3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 176 citations in OpenAlex.

  1. Biophysical principles of pulsed field ablation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Review
  2. Article
  3. Article
  4. Reversible electroporation for cancer therapy.The British journal of radiology · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

I EdhemovicInstitute of Oncology Ljubljana, Zaloska 2, SI-1000 Ljubljana, Slovenia.
E M Gadzijev
E Brecelj
D Miklavcic
B Kos
A Zupanic
B Mali
T Jarm
D Pavliha
M Marcan
G Gasljevic
V Gorjup
M Music
T Pecnik Vavpotic
M Cemazar
M Snoj
G Sersa
Institute of Oncology Ljubljana · SIUniversity of Ljubljana · SILjubljana University Medical Centre · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electrochemotherapy is now in development for treatment of deep-seated tumors, like in bones and internal organs, such as liver. The technology is available with a newly developed electric pulse generator and long needle electrodes; however the procedures for the treatment are not standardized yet. In order to describe the treatment procedure, including treatment planning, within the ongoing clinical study, a case of successful treatment of a solitary metastasis in the liver of colorectal cancer is presented. The procedure was performed intraoperatively by inserting long needle electrodes, two in the center of the tumor and four around the tumor into the normal tissue. The insertion of electrodes proved to be feasible and was done according to the treatment plan, prepared by numerical modeling. After intravenous bolus injection of bleomycin the tumor was exposed to electric pulses. The delivery of the electric pulses did not interfere with functioning of the heart, since the pulses were synchronized with electrocardiogram in order to be delivered outside the vulnerable period of the ventricles. Also the post treatment period was uneventful without side effects. Re-operation of the treated metastasis demonstrated feasibility of the reoperation, without secondary effects of electrochemotherapy on normal tissue. Good antitumor effectiveness with complete tumor destruction was confirmed with histological analysis. The patient is disease-free 16 months after the procedure. In conclusion, treatment procedure for electrochemotherapy proved to be a feasible technological approach for treatment of liver metastasis. Due to the absence of the side effects and the first complete destruction of the treated tumor, treatment procedure for electrochemotherapy seems to be a safe method for treatment of liver metastases with good treatment effectiveness even in difficult-to-reach locations.

Indexed as

Antibiotics, AntineoplasticAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsBevacizumabBleomycinCapecitabineCarcinomaCombined Modality TherapyDeoxycytidineElectrochemotherapyFeasibility StudiesFemaleFluorouracilHumansLiverLiver NeoplasmsAntibiotics, AntineoplasticAntibodies, Monoclonal, HumanizedBevacizumabBleomycinCapecitabineDeoxycytidineFluorouracilOxaloacetates

Identifiers

PMID21895032
PMCPMC4527414
OpenAlexW2169652500

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.